Joly
P
et al; French study group on autoimmune bullous skin diseases. First-line
rituximab combined with short-term
prednisone versus
prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 2017 May 20;389(10083):2031–40.
[PubMed: 28342637]